Ontogeny of Tumor-Associated Macrophages and Its Implication in Cancer Regulation

Trends in Cancer

Volumn 2, Issue 1, 2016, Pages 20-34

  Franklin, Ruth A ^a,b   Li, Ming O ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGENESIS; CELL DENSITY; CELL EXPANSION; EMBRYO DEVELOPMENT; HUMAN; IMMUNITY; INFLAMMATION; MACROPHAGE; MACROPHAGE FUNCTION; MALIGNANT NEOPLASM; MONOCYTE; NONHUMAN; ONTOGENY; PRIORITY JOURNAL; REVIEW; STEADY STATE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT;

EID: 85009115863     PISSN: 24058033     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trecan.2015.11.004     Document Type: Review

References (145)

1. 1 Davies, L.C., et al. Tissue-resident macrophages. Nat. Immunol. 14 (2013), 986–995.
2. 2 Wynn, T.A., et al. Macrophage biology in development, homeostasis and disease. Nature 496 (2013), 445–455.
3. 3 Gentek, R., et al. Tissue macrophage identity and self-renewal. Immunol. Rev. 262 (2014), 56–73.
4. 4 Sieweke, M.H., Allen, J.E., Beyond stem cells: self-renewal of differentiated macrophages. Science, 342, 2013, 1242974.
5. 5 Jakubzick, C., et al. Minimal differentiation of classical monocytes as they survey steady-state tissues and transport antigen to lymph nodes. Immunity 39 (2013), 599–610.
6. 6 Tamoutounour, S., et al. Origins and functional specialization of macrophages and of conventional and monocyte-derived dendritic cells in mouse skin. Immunity 39 (2013), 925–938.
7. 7 Bain, C.C., et al. Constant replenishment from circulating monocytes maintains the macrophage pool in the intestine of adult mice. Nat. Immunol. 15 (2014), 929–937.
8. 8 Zigmond, E., et al. Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells. Immunity 37 (2012), 1076–1090.
9. 9 Franklin, R.A., et al. The cellular and molecular origin of tumor-associated macrophages. Science 344 (2014), 921–925.
10. 10 Epelman, S., et al. Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity 40 (2014), 91–104.
11. 11 Epelman, S., et al. Origin and functions of tissue macrophages. Immunity 41 (2014), 21–35.
12. 12 Ginhoux, F., Jung, S., Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat. Rev. Immunol. 14 (2014), 392–404.
13. 13 Gomez Perdiguero, E., Geissmann, F., Myb-independent macrophages: a family of cells that develops with their tissue of residence and is involved in its homeostasis. Cold Spring Harb. Symp. Quant. Biol. 78 (2013), 91–100.
14. 14 Orkin, S.H., Zon, L.I., Hematopoiesis: an evolving paradigm for stem cell biology. Cell 132 (2008), 631–644.
15. 15 Hoeffel, G., et al. C-Myb(+) erythro-myeloid progenitor-derived fetal monocytes give rise to adult tissue-resident macrophages. Immunity 42 (2015), 665–678.
16. 16 Hoeffel, G., Ginhoux, F., Ontogeny of tissue-resident macrophages. Front. Immunol., 6, 2015, 486.
17. 17 Frame, J.M., et al. Erythro-myeloid progenitors: ‘definitive’ hematopoiesis in the conceptus prior to the emergence of hematopoietic stem cells. Blood Cells Mol. Dis. 51 (2013), 220–225.
18. 18 Lin, Y., et al. Lymphoid progenitor emergence in the murine embryo and yolk sac precedes stem cell detection. Stem Cells Dev. 23 (2014), 1168–1177.
19. 19 Palis, J., et al. Development of erythroid and myeloid progenitors in the yolk sac and embryo proper of the mouse. Development 126 (1999), 5073–5084.
20. 20 Kieusseian, A., et al. Immature hematopoietic stem cells undergo maturation in the fetal liver. Development 139 (2012), 3521–3530.
21. 21 Samokhvalov, I.M., et al. Cell tracing shows the contribution of the yolk sac to adult haematopoiesis. Nature 446 (2007), 1056–1061.
22. 22 Ginhoux, F., et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330 (2010), 841–845.
23. 23 Schulz, C., et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 336 (2012), 86–90.
24. 24 Mucenski, M.L., et al. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 65 (1991), 677–689.
25. 25 Gomez Perdiguero, E., et al. Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature 518 (2015), 547–551.
26. 26 Kierdorf, K., et al. Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nat. Neurosci. 16 (2013), 273–280.
27. 27 Sheng, J., et al. Most tissue-resident macrophages except microglia are derived from fetal hematopoietic stem cells. Immunity 43 (2015), 382–393.
28. 28 Daneman, R., et al. Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 468 (2010), 562–566.
29. 29 Hashimoto, D., et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity 38 (2013), 792–804.
30. 30 Ghigo, C., et al. Multicolor fate mapping of Langerhans cell homeostasis. J. Exp. Med. 210 (2013), 1657–1664.
31. 31 Kissenpfennig, A., et al. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22 (2005), 643–654.
32. 32 Davies, L.C., et al. Distinct bone marrow-derived and tissue-resident macrophage lineages proliferate at key stages during inflammation. Nat. Commun., 4, 2013, 1886.
33. 33 Davies, L.C., et al. A quantifiable proliferative burst of tissue macrophages restores homeostatic macrophage populations after acute inflammation. Eur. J. Immunol. 41 (2011), 2155–2164.
34. 34 Tagliani, E., et al. Coordinate regulation of tissue macrophage and dendritic cell population dynamics by CSF-1. J. Exp. Med. 208 (2011), 1901–1916.
35. 35 Ajami, B., et al. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat. Neurosci. 10 (2007), 1538–1543.
36. 36 Chorro, L., et al. Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC network. J. Exp. Med. 206 (2009), 3089–3100.
37. 37 Jenkins, S.J., et al. Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science 332 (2011), 1284–1288.
38. 38 Van Gassen, N., et al. Macrophage dynamics are regulated by local macrophage proliferation and monocyte recruitment in injured pancreas. Eur. J. Immunol. 45 (2015), 1482–1493.
39. 39 Ginhoux, F., et al. Langerhans cells arise from monocytes in vivo. Nat. Immunol. 7 (2006), 265–273.
40. 40 Robbins, C.S., et al. Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat. Med. 19 (2013), 1166–1172.
41. 41 Shi, C., Pamer, E.G., Monocyte recruitment during infection and inflammation. Nat. Rev. Immunol. 11 (2011), 762–774.
42. 42 Geissmann, F., et al. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19 (2003), 71–82.
43. 43 Jung, S., et al. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol. 20 (2000), 4106–4114.
44. 44 Nahrendorf, M., et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 204 (2007), 3037–3047.
45. 45 Auffray, C., et al. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 317 (2007), 666–670.
46. 46 Hanna, R.N., et al. The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C- monocytes. Nat. Immunol. 12 (2011), 778–785.
47. 47 Carlin, L.M., et al. Nr4a1-dependent Ly6C(low) monocytes monitor endothelial cells and orchestrate their disposal. Cell 153 (2013), 362–375.
48. 48 Biburger, M., et al. Monocyte subsets responsible for immunoglobulin G-dependent effector functions in vivo. Immunity 35 (2011), 932–944.
49. 49 Mildner, A., et al. A close encounter of the third kind: monocyte-derived cells. Adv. Immunol. 120 (2013), 69–103.
50. 50 Yona, S., et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 38 (2013), 79–91.
51. 51 Haldar, M., et al. Heme-mediated SPI-C induction promotes monocyte differentiation into iron-recycling macrophages. Cell 156 (2014), 1223–1234.
52. 52 Calderon, B., et al. The pancreas anatomy conditions the origin and properties of resident macrophages. J. Exp. Med. 212 (2015), 1497–1512.
53. 53 Molawi, K., et al. Progressive replacement of embryo-derived cardiac macrophages with age. J. Exp. Med. 211 (2014), 2151–2158.
54. 54 Ramachandran, P., et al. Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis. Proc. Natl. Acad. Sci. U.S.A. 109 (2012), E3186–E3195.
55. 55 Stables, M.J., et al. Transcriptomic analyses of murine resolution-phase macrophages. Blood 118 (2011), e192–e208.
56. 56 Tacke, F., et al. Monocyte subsets differentially employ CCR2 CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J. Clin. Invest. 117 (2007), 185–194.
57. 57 Arnold, L., et al. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J. Exp. Med. 204 (2007), 1057–1069.
58. 58 Shechter, R., et al. Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med., 6, 2009, e1000113.
59. 59 Egawa, M., et al. Inflammatory monocytes recruited to allergic skin acquire an anti-inflammatory M2 phenotype via basophil-derived interleukin-4. Immunity 38 (2013), 570–580.
60. 60 De Palma, M., Lewis, C.E., Macrophage regulation of tumor responses to anticancer therapies. Cancer Cell 23 (2013), 277–286.
61. 61 Qian, B.Z., Pollard, J.W., Macrophage diversity enhances tumor progression and metastasis. Cell 141 (2010), 39–51.
62. 62 Sica, A., Mantovani, A., Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 122 (2012), 787–795.
63. 63 De Palma, M., et al. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8 (2005), 211–226.
64. 64 De Palma, M., et al. Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat. Med. 9 (2003), 789–795.
65. 65 Movahedi, K., et al. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res. 70 (2010), 5728–5739.
66. 66 DeNardo, D.G., et al. CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 16 (2009), 91–102.
67. 67 Lin, E.Y., et al. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J. Exp. Med. 193 (2001), 727–740.
68. 68 Franklin, R.A., Li, M.O., The ontogeny of tumor-associated macrophages: a new understanding of cancer–elicited inflammation. Oncoimmunology, 3, 2014, e955346.
69. 69 Tymoszuk, P., et al. In situ proliferation contributes to accumulation of tumor-associated macrophages in spontaneous mammary tumors. Eur. J. Immunol. 44 (2014), 2247–2262.
70. 70 Bonapace, L., et al. Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis. Nature 515 (2014), 130–133.
71. 71 Campbell, M.J., et al. Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome. Breast Cancer Res. Treat. 128 (2011), 703–711.
72. 72 Laoui, D., et al. Tumor hypoxia does not drive differentiation of tumor-associated macrophages but rather fine-tunes the M2-like macrophage population. Cancer Res. 74 (2014), 24–30.
73. 73 Cortez-Retamozo, V., et al. Origins of tumor-associated macrophages and neutrophils. Proc. Natl. Acad. Sci. U.S.A. 109 (2012), 2491–2496.
74. 74 Shand, F.H., et al. Tracking of intertissue migration reveals the origins of tumor-infiltrating monocytes. Proc. Natl. Acad. Sci. U.S.A. 111 (2014), 7771–7776.
75. 75 Guilliams, M., et al. Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF. J. Exp. Med. 210 (2013), 1977–1992.
76. 76 Schneider, C., et al. Induction of the nuclear receptor PPAR-gamma by the cytokine GM-CSF is critical for the differentiation of fetal monocytes into alveolar macrophages. Nat. Immunol. 15 (2014), 1026–1037.
77. 77 Kang, T.W., et al. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 479 (2011), 547–551.
78. 78 Du, R., et al. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 13 (2008), 206–220.
79. 79 Pyonteck, S.M., et al. CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat. Med. 19 (2013), 1264–1272.
80. 80 Gabrilovich, D.I., et al. Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 12 (2012), 253–268.
81. 81 Henson, P.M., Hume, D.A., Apoptotic cell removal in development and tissue homeostasis. Trends Immunol. 27 (2006), 244–250.
82. 82 Pollard, J.W., Trophic macrophages in development and disease. Nat. Rev. Immunol. 9 (2009), 259–270.
83. 83 Wynn, T.A., Cellular and molecular mechanisms of fibrosis. J. Pathol. 214 (2008), 199–210.
84. 84 Ajami, B., et al. Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat. Neurosci. 14 (2011), 1142–1149.
85. 85 Saijo, K., et al. A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 137 (2009), 47–59.
86. 86 Gosselin, D., et al. Environment drives selection and function of enhancers controlling tissue-specific macrophage identities. Cell 159 (2014), 1327–1340.
87. 87 Lavin, Y., et al. Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. Cell 159 (2014), 1312–1326.
88. 88 Gautier, E.L., et al. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat. Immunol. 13 (2012), 1118–1128.
89. 89 Parkhurst, C.N., et al. Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell 155 (2013), 1596–1609.
90. 90 Paolicelli, R.C., et al. Synaptic pruning by microglia is necessary for normal brain development. Science 333 (2011), 1456–1458.
91. 91 Schafer, D.P., et al. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 74 (2012), 691–705.
92. 92 Chow, A., et al. CD169(+) macrophages provide a niche promoting erythropoiesis under homeostasis and stress. Nat. Med. 19 (2013), 429–436.
93. 93 Kohyama, M., et al. Role for Spi-C in the development of red pulp macrophages and splenic iron homeostasis. Nature 457 (2009), 318–321.
94. 94 Okabe, Y., Medzhitov, R., Tissue-specific signals control reversible program of localization and functional polarization of macrophages. Cell 157 (2014), 832–844.
95. 95 Iwasaki, A., Medzhitov, R., Control of adaptive immunity by the innate immune system. Nat. Immunol. 16 (2015), 343–353.
96. 96 Wu, J., Chen, Z.J., Innate immune sensing and signaling of cytosolic nucleic acids. Annu. Rev. Immunol. 32 (2014), 461–488.
97. 97 Mosser, D.M., Edwards, J.P., Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8 (2008), 958–969.
98. 98 Murray, P.J., et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41 (2014), 14–20.
99. 99 Gordon, S., Alternative activation of macrophages. Nat. Rev. Immunol. 3 (2003), 23–35.
100. 100 Lauvau, G., et al. Inflammatory monocyte effector mechanisms. Cell. Immunol. 291 (2014), 32–40.
101. 101 Serbina, N.V., et al. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 19 (2003), 59–70.
102. 102 Copin, R., et al. MyD88-dependent activation of B220-CD11b+LY-6C+ dendritic cells during Brucella melitensis infection. J. Immunol. 178 (2007), 5182–5191.
103. 103 Peters, W., et al. Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U.S.A. 98 (2001), 7958–7963.
104. 104 Barbalat, R., et al. Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands. Nat. Immunol. 10 (2009), 1200–1207.
105. 105 Hohl, T.M., et al. Inflammatory monocytes facilitate adaptive CD4 T cell responses during respiratory fungal infection. Cell Host Microbe 6 (2009), 470–481.
106. 106 Leon, B., et al. Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity 26 (2007), 519–531.
107. 107 Narni-Mancinelli, E., et al. Inflammatory monocytes and neutrophils are licensed to kill during memory responses in vivo. PLoS Pathog., 7, 2011, e1002457.
108. 108 Robben, P.M., et al. Recruitment of Gr-1+ monocytes is essential for control of acute toxoplasmosis. J. Exp. Med. 201 (2005), 1761–1769.
109. 109 Aldridge, J.R. Jr., et al. TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc. Natl. Acad. Sci. U.S.A. 106 (2009), 5306–5311.
110. 110 Bosschaerts, T., et al. Tip-DC development during parasitic infection is regulated by IL-10 and requires CCL2/CCR2 IFN-gamma and MyD88 signaling. PLoS Pathog., 6, 2010, e1001045.
111. 111 Bingle, L., et al. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J. Pathol. 196 (2002), 254–265.
112. 112 Zhang, Q.W., et al. Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature. PLoS ONE, 7, 2012, e50946.
113. 113 Ruffell, B., et al. Differential macrophage programming in the tumor microenvironment. Trends Immunol. 33 (2012), 119–126.
114. 114 Noy, R., Pollard, J.W., Tumor-associated macrophages: from mechanisms to therapy. Immunity 41 (2014), 49–61.
115. 115 Colegio, O.R., et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 513 (2014), 559–563.
116. 116 Lin, E.Y., et al. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res. 66 (2006), 11238–11246.
117. 117 Yeo, E.J., et al. Myeloid WNT7b mediates the angiogenic switch and metastasis in breast cancer. Cancer Res. 74 (2014), 2962–2973.
118. 118 Mazzieri, R., et al. Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells. Cancer Cell 19 (2011), 512–526.
119. 119 Gocheva, V., et al. IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes Dev. 24 (2010), 241–255.
120. 120 Engelhardt, J.J., et al. Marginating dendritic cells of the tumor microenvironment cross-present tumor antigens and stably engage tumor-specific T cells. Cancer Cell 21 (2012), 402–417.
121. 121 Norian, L.A., et al. Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism. Cancer Res. 69 (2009), 3086–3094.
122. 122 Biswas, S.K., et al. Tumor-associated macrophages: functional diversity, clinical significance, and open questions. Semin. Immunopathol. 35 (2013), 585–600.
123. 123 Ostuni, R., et al. Macrophages and cancer: from mechanisms to therapeutic implications. Trends Immunol. 36 (2015), 229–239.
124. 124 Lahmar, Q., et al. Tissue-resident versus monocyte-derived macrophages in the tumor microenvironment. Biochim. Biophys. Acta, 2015, 10.1016/j.bbcan.2015.06.009 Published online July 2, 2015.
125. 125 Ruffell, B., et al. Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells. Cancer Cell 26 (2014), 623–637.
126. 126 Casazza, A., et al. Impeding macrophage entry into hypoxic tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity. Cancer Cell 24 (2013), 695–709.
127. 127 Broz, M.L., et al. Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity. Cancer Cell 26 (2014), 638–652.
128. 128 Egeblad, M., et al. Visualizing stromal cell dynamics in different tumor microenvironments by spinning disk confocal microscopy. Dis. Model. Mech. 1 (2008), 155–167 discussion 165.
129. 129 Wyckoff, J.B., et al. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res. 67 (2007), 2649–2656.
130. 130 Pucci, F., et al. A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood ‘resident’ monocytes, and embryonic macrophages suggests common functions and developmental relationships. Blood 114 (2009), 901–914.
131. 131 Mitchem, J.B., et al. Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses. Cancer Res. 73 (2013), 1128–1141.
132. 132 Szulzewsky, F., et al. Glioma-associated microglia/macrophages display an expression profile different from M1 and M2 polarization and highly express Gpnmb and Spp1. PLoS ONE, 10, 2015, e0116644.
133. 133 Squadrito, M.L., et al. miR-511-3p modulates genetic programs of tumor-associated macrophages. Cell Rep. 1 (2012), 141–154.
134. 134 Hanahan, D., Coussens, L.M., Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 21 (2012), 309–322.
135. 135 Sharma, P., Allison, J.P., The future of immune checkpoint therapy. Science 348 (2015), 56–61.
136. 136 Chitu, V., Stanley, E.R., Colony-stimulating factor-1 in immunity and inflammation. Curr. Opin. Immunol. 18 (2006), 39–48.
137. 137 Laoui, D., et al. Functional relationship between tumor-associated macrophages and macrophage colony-stimulating factor as contributors to cancer progression. Front. Immunol., 5, 2014, 489.
138. 138 DeNardo, D.G., et al. Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov. 1 (2011), 54–67.
139. 139 Strachan, D.C., et al. CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8 T cells. Oncoimmunology, 2, 2013, e26968.
140. 140 Quail, D.F., Joyce, J.A., Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 19 (2013), 1423–1437.
141. 141 Beatty, G.L., et al. CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. Science 331 (2011), 1612–1616.
142. 142 Coussens, L.M., et al. Neutralizing tumor-promoting chronic inflammation: a magic bullet?. Science 339 (2013), 286–291.
143. 143 Klemm, F., Joyce, J.A., Microenvironmental regulation of therapeutic response in cancer. Trends Cell Biol. 25 (2015), 198–213.
144. 144 Mantovani, A., Allavena, P., The interaction of anticancer therapies with tumor-associated macrophages. J. Exp. Med. 212 (2015), 435–445.
145. 145 Zitvogel, L., et al. Immune parameters affecting the efficacy of chemotherapeutic regimens. Nat. Rev. Clin. Oncol. 8 (2011), 151–160.